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Participation of the myeloperoxidase-H2o2-halide system in immune
complex nephritis. Neutrophils (PMNs) mediate injury in experimental
glomerulonephritis (GN) in part via the release of reactive oxygen
species, particularly hydrogen peroxide (H202). Recent kidney perfu-
sion studies demonstrate that H202 can cause glomerular injury by
reaction with halides in the presence of the PMN cationic enzyme
myeloperoxidase (MPO) to form oxidants which can oxidize and
halogenate tissue. We sought evidence for participation of the MPO
system in a model of PMN-mediated immune complex (IC) GN, A
PMN-dependent model of GN was developed in rats by perfusing the
renal artery with concanavalin A followed by anticoncanavalin A
antibody. PMN depletion abolished glomerular PMN infiltration and
significantly reduced proteinuria (35 7 mg/day vs. 113 10, P <
0.001). Rats that received Na'251 (5.0 s Ci) three and six hours following
disease induction had more 1251 incorporation in glomeruli and GBM at
48 hours than similarly treated rats that were PMN depleted (1200 cpm
vs. 88 cpm, P < 0.01). Glomenilar iodination could not be demonstrated
in a PMN-independent model of nephrotoxic nephritis induced with
noncomplement fixing anti-GBM antibody. These data indicate that this
model of PMN-mediated IC GN is associated with activation of the
MPO-H2O2-haljde system, which may participate in mediating glomer-
ular injury.
Neutrophils (PMNs) play a major role in the pathogenesis of
some types of antibody-mediated proliferative glomerulone-
phritis (GN). The importance of PMNs in human disease is
suggested by their frequent presence in glomeruli in diseases
such as anti-glomerular basement membrane (anti-GBM) ne-
phritis [1], diffuse proliferative lupus nephritis [2], and post-
infectious glomerulonephritis [31. Further evidence is provided
from studies of experimentally-induced anti-GBM disease in the
rabbit and rat [4—6]. In these models the administration of a
complement-dependent anti-GBM antibody to animals that
have been previously depleted of PMNs results in reduced
glomerular PMN infiltration and significantly less proteinuria
than normal controls [4, 51. If exogenous PMNs are infused
back into these leukopenic animals, the glomerular injury and
proteinuria can be partially restored [61.
The mechanism by which PMNs damage glomeruli has been
attributed to release of lysosomal proteases [7] which can injure
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endothelial cells [8] and basement membrane [9—Ill. Recent
studies, however, have demonstrated the importance of reac-
tive oxygen species (ROS) [12—161, presumably released from
the PMN following interaction with immune complexes [17—18]
or complement activation products such as C5a l9]. These
highly reactive products of oxygen reduction and excitation
include superoxide anion (Of), hydrogen peroxide (H202),
hydroxyl radical ( OH), and possibly singlet oxygen ('02).
The principal ROS involved in PMN-dependent GN appears
to be H202 [14—161. In disease models in the rat in which the
renal artery is perfused with phorbol myristate acetate (which
activates PMNs), cobra venom factor (which activates comple-
ment) or anti-GBM antibody, proteinuria can be significantly
decreased by pretreating the rats with catalase, an enzyme that
degrades H202 to oxygen and water [14—16]. In contrast, neither
superoxide dismutase (which scavenges 07) or dimethyl
sulfoxide (which scavenges . OH) were protective in these
models [14—161.
A potential mechanism for H202 action is its reaction with
halides (CL, Br, I) in the presence of the neutrophil enzyme
myeloperoxidase (MPO) to form hypohalous acids, halogens
and other long lived oxidants [20, 21]. We recently demon-
strated that this system can induce glomerular injury in
perfused kidneys [221. MPO infused into the renal artery of rats
followed by H202 and halides results in significant histologic
glomerular injury, proteinuria and halogenation of GBM [221. In
this study we demonstrate that PMN-mediated immune com-
plex GN is also associated with halogenation of glomerular
structures in vivo. As this reaction is dependent on the action of
MPO [20, 23], this finding supports the hypothesis that the MPO
system participates in mediating PMN-dependent GN.
Methods
Production of immune complex GN
In situ immune complex GN was induced in rats by a
variation of the method originally described by Golbus and
Wilson [24], in which the left renal artery of rats is perfused
with the lectin concanavalin A (con A) (Miles, Naperville,
Illinois, USA) followed by antibody to con A (anti-con A) given
intravenously. The binding of con A to glucose and mannose
residues in GBM glycoprotein [25] results in localization of the
leetin on the glomerular capillary wall where it then serves as a
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planted antigen in the initiation of ON. Unlike the originally
described model, in our studies the anticon A was administered
via the renal artery.
Renal artery perfusion
Sprague Dawley rats (Tyler, Bellevue, Washington, USA),
weighing between 220 and 300 grams, were anesthetized with
chioral hydrate (0.1 ml of a 3.6% solution/lO g wt i.p.). The left
renal artery was isolated, blood flow interrupted, and the artery
cannulated with a 30 gauge needle as previously described [22].
The artery was then perfused with 0.5 ml phosphate buffered
saline pH 7.2 (PBS) to displace blood from the kidney, followed
by con A antigen 125 g in 0.3 ml PBS. Additional PBS (0.2 ml)
was given to clear unbound con A from the renal vascular
space, followed by 25 mg of anti-con A IgG, or normal rabbit
IgG, in 0.5 ml PBS. All perfusions were carried out using a
constant infusion pump (Sage Instruments, Cambridge Massa-
chusetts, USA) at a rate of 0.5 mI/mm. Following perfusion, the
needle was removed and bleeding stopped with gentle pressure
and gelfoam (Upjohn Company, Kalamazoo Michigan, USA).
Kidneys that did not reperfuse and recover a normal appear-
ance were not studied further. Total ischemia time did not
exceed eight minutes. The unperfused right kidney was re-
moved prior to closing the abdominal incision.
Experimental design
Three groups of rats were studied. Thirteen animals with con
A-anticon A nephritis served as the experimental group. A
control group of five rats were perfused with con A followed by
normal rabbit IgG to exclude any effect of con A localization
alone on the results observed. Six rats were depleted of PMNs
to less than 250/mm3 with specific rabbit anti-rat PMN antibody
(ANS) prior to induction of disease to document the role of
PMNs in mediating the glomerular injury. In all animals, urine
was collected in metabolic cages with free access to water from
24 to 48 hours after disease induction for measurement of urine
protein excretion by a sulfosalicylic acid method using a com-
mercial protein standard [261. At 48 hours the serum creatinine
was measured using a picric acid method (Worthington Diag-
nostics, Freehold, New Jersey, USA), and a renal biopsy was
obtained for study by light, immunofluorescence and electron
microscopy. Some animals in each group received '251-iodide
three and six hours after disease induction, and glomerular and
GBM incorporation of 1251 as an index of halogenation of
glomerular structures was measured at the time of sacrifice at 48
hours.
Antibody to concanavalin A (anticon A)
Anticon A antibody was produced in New Zealand white
rabbits (R & R, Stanwood, Washington, USA). Each rabbit was
injected with 3 mg con A in complete Freund's adjuvant (Difco,
Detroit, Michigan, USA) and boosted two times at one month
intervals with 1 mg con A in incomplete Freund's adjuvant
(Difco). Sera was collected over a three month period beginning
two weeks after the last immunization, pooled, and heat inac-
tivated at 56°C for 30 minutes. An IgG enriched fraction was
obtained by precipitation with 50 percent ammonium sulfate,
and the IgG was then re-dissolved and dialyzed against PBS.
The protein content was determined spectrophotometrically
using an extinction coefficient (E) of 14.0. Antibody activity
against con A was verified by precipitin analysis in micro-
Ouchterlony plates. Dose response studies documented that 25
mg of IgG was an optimal dose to induce disease utilizing the
above protocol. Normal rabbit IgG (RbIgG) was prepared from
a 50 percent ammonium sulfate precipitate of normal heat
inactivated (56°C x 30 minutes) rabbit serum.
Antibody to rat neutrophi!s (ANS)
ANS was produced in New Zealand white rabbits. Rats were
injected intraperitoneally with 0.1% oyster glycogen (Sigma, St.
Louis, Missouri, USA) twice three days apart, Three hours
following the second injection, the neutrophils were harvested
by peritoneal lavage using Hanks balanced salt solution without
calcium or magnesium [27], and then further purified using a
Ficoll Hypaque density gradient sedimentation (Pharmacia,
Piscataway, New Jersey, USA) and hypotonic lysis to remove
erythrocytes [281. Each rabbit was then injected subcutane-
ously and intramuscularly in multiple sites with a total of 6 X
106 rat neutrophils in incomplete Freund's adjuvant (Difco).
After three weeks, the rabbits were bled and the serum exten-
sively absorbed with rat thymocytes, peritoneal macrophages
and red cells. The purified preparation did not react with rat
serum by immunoprecipitin analysis, depress serum C3 levels
measured by radial immunodiffusion over a 24 hour period [291,
or cause proteinuria at doses that resulted in neutropenia.
Administration of ANS did not alter the hematocrit, but did
depress lymphocyte and monocyte counts by approximately 25
to 30%. Rats were depleted of PMNs to < 250/mm3 (normal
range 2000 to 4000/mm3) with ANS given as 1.5 ml intrave-
nously six hours before the kidney perfusion and 1.0 ml
intravenously every 12 hours afterwards for three additional
doses.
Demonstration of gloinerular iodina lion
Halogenation of glomerular structures were documented by
measuring the incorporation of 1251 into whole glomeruli and
GBM. Following the initial renal artery perfusion with con A
and anticon A, the rats were injected at three hours with 5.0 Ci
125j intravenously and again at six hours with 5.0 pCi 125j
intraperitoneally. The uptake of 125J into isolated whole glomer-
uli and GBM was determined at 48 hours. Prior to isolation of
glomeruli the left kidney was perfused with 60 ml of PBS via the
superior mesenteric artery [301. The kidney was then removed
and the glomeruli isolated by differential sieving techniques
[301. Previous studies have shown that rat glomeruli isolated by
this technique contained no detectable blood contamination
[30]. The total counts per minute (cpm) in a washed glomerular
pellet was determined using a Prias scintillation counter
(Packard Instrument Co., Donners Grove, Illinois, USA) and
the total number of glomeruli were determined by visual count-
ing using a Fuchs-Rosenthal counting chamber (Hausser Scien-
tific Co., Blue Bell, Pennsylvania, USA) [30]. The amount of
iodine incorporation into GBM was determined by suspending
the washed glomerular pellet in 2.0 ml PBS and sonicating in 30
seconds bursts at 4°C using a Branson sonicator at a setting of
6 (Branson Instruments, Danbury, Connecticut, USA). [31].
GBM was separated from cellular fragments on a #200 sieve
and washed three times in cold PBS prior to counting. Exami-
nation of the washed pellets by light microscopy reveled no
significant cellular contamination. The amount of iodination for
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Fig. 1. Light microscopy of a glomerulus ofa rat perfused with con A-anti-con A (A), con A - normal RbIgG (B) and con A - anti-con A in the
presence of neutropenia (C). In con A -anti-con A UN hypercellularity with abundant PMNs is present. The control groups demonstrate normal
morphology (periodic acid Schiff stain, x 300).
both isolated whole glomeruli and GBM preparations was
expressed as the CPM/38,000 glomeruli to correspond with the
number of glomeruli present in an intact rat kidney [321.
To exclude the possibility that glomerular incorporation of
125j was a nonspecific effect of glomerular injury independent of
PMNs, similar studies were performed in two rats that were
injected with 20 mg of the gamma 2 (non-complement fixing)
fraction of sheep antirat GBM antibody [331. Urine protein
excretion from 24 to 48 hours were 284 and 234 mg, respec-
tively. Studies previously peformed in our laboratory have
documented that proteinuria in the heterologous phase of this
sheep antirat GBM model is independent of complement and
PMNs (data not shown).
Renal pathology
Renal tissue obtained at 48 hours was processed for routine
light, immunolluorescence and electron microscopy as de-
scribed previously 34]. Sections for light microscopy were
stained with periodic acid-Schiff reagent and hemotoxylin and
eosin. Quantitation of PMNs present in 12 random glomeruli
from each rat biopsy was performed and expressed as the mean
number of neutrophils present per glomerulus. Immunofluores-
cence was performed on tissue snap frozen in dry ice-
isopentane [34]. The presence of con A antigen was determined
by indirect immunofluorescence utilizing goat anti-con A anti-
body (Miles Laboratories, Naperville, Illinois, USA) followed
by FITC-conjugated sheep anti-IgG (Cappel Laboratories,
Cochranville, Pennsylvania, USA). The latter antibody did not
cross react with rabbit IgG at the dilution used. The presence of
rabbit anti-con A IgG was determined using FITC-conjugated
goat anti-rabbit IgG, and rat C3 was stained with FITC-
conjugated goat anti-rat C3 (Cappel Laboratories). Stained
sections were examined on a Leitz Ortholux II microscope with
a Ploempak 2.2 vertical fluorescence illuminator and appropri-
ate filters for FITC fluorescence (E. Leitz Inc., Rockleigh, New
Jersey, USA). Sections were photographed on Kodak Ekta-
chrome ED-l35 film (Eastman Kodak Company, Rochester,
New York, USA) with an automatic exposure meter. The
intensity of fluorescence was evaluated semi-quantitatively as
described previously [33]. Tissue for electron microscopy was
fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer, pH 7.0,
postfixed in 1% osmium tetroxide for two hours, dehydrated in
graded ethanols and embedded in epoxy resin. Thin sections
were stained on the grid with uranyl acetate and lead citrate and
examined with a Philips 410 electron microscope (Philips,
Brussels, Belgium).
Analysis of data
All values are expressed as mean SE. Comparisons be-
tween groups were made utilizing the Student's t-test.
Results
Description of disease model
The intrarenal perfusion of con A followed by anti-con A
resulted in an immune complex ON with hypercellularity due
primarily to an increase in neutrophils and monocytes noted at
48 hours (Fig. IA). In contrast, rats perfused with con A and
normal RbIgG had essentially normal morphology by light
microscopy (Fig 1B). The number of neutrophils present per
glomerulus at 48 hours was significantly greater in the con
A-anti-con A rats than in control rats receiving con A and
normal RbIgG (5.8 0,5 PMNs/glomerulus vs. 0.17 0.1
PMNfglomerulus, respectively; P < 0.001) (Table 1). There was
no evidence of glomerular crescent formation or glomerular
thrombosis by light microscopy.
By immunofluorescence, rats given con A - anti-con A had
rabbit IgG, rat C3, and con A distributed along the glomerular
capillary wall in a linear-granular pattern at 48 hours (Fig. 2).
However, rats given con A - normal normal RbIgG had negative
immunofluorescence for RbIgG and rat C3 and only trace
deposits of con A at 48 hours. By electron microscopy, rats
with con A -anti-con A disease had prominent band-like,
electron dense subendothelial deposits that extended into the
lamina rara interna of the GBM (Fig. 3). In occasional sections
deposits could also be found in the subepithelial space. Numer-
ous PMNs were present in the glomerular capillary loops, many
of them displacing endothelial cells and lying adjacent to the
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Table 1. Protein excretion, serum creatinine, histology and iodination in con A-anti-con A GN and two control groupsa
Experimental group
Urine
protein
excretion
day l—2
mg124 hr
Serum
creatinine at
48 hr ing/di
Histology lodination
PMN/
glomerulus
Immunofluorescence cpm/ cpm/
38,000 GBM
glomeruli prpbCon A RB lgG RtC3
Con A-anti-con A 112.6 97C
(N = 13)
1.52 0.l31
(N = 6)
5.8 0.5C
(N = 7)
2+ 3+ 2+ 1202 184C 384 71
(N = 6) (N = 6)
Con A-normal 9.7 2.1 1.01 0.07 0.17 0.1 tr .— — 45 14 5 2
Rb IgG (N = 5) (N 4) (N = 5) (N = 3) (N = 3)
Con A-anti-con A 34.9 6.8 0.98 0.14 0.36 0.1 2+ 3+ 2+ 88 3 16 4
(PMN depleted) (N = 6) (N = 4) (N = 6) (N = 4) (N = 4)
a The mean SE is shown and the number of rats is given in parentheses
b Expressed as cpm in GBM extracted from 38,000 glomeruli
P < 0.001, ' P < 0.05, a p < 0.01, all relative to control groups
deposits. In some sections, platelets and mononuclear cells
were also prevalent. Focal epithelial cell foot process efface-
ment was also present, but no discontinuities of the GBM were
noted. In contrast, rats that had been perfused with con A -
normal RbIgG had no deposits, no inflammatory cell infiltrates
and no epithelial cell changes (Fig. 3).
Rats perfused with con A - anti-con A excreted significantly
more protein from 24 to 48 hours after perfusion than control
rats given con A - normal RbIgG (112.6 9.7 mg/24 hr vs. 9.7
2.1 mg/24 hr, P <0.001) (Table 1). Serum creatinine at 48
hours was also significantly higher in the rats given con A -
anti-con A than in the control rats given con A -normal RbIgG
(1.52 0.13 mg/dl vs. 1.01 0.07 /mg/dl, respectively; P <
0.05) (Table I).
Effect of neutrophil depletion
Six rats were maintained neutropenic (PMN < 250/mm3)
beginning before the renal perfusion and continuing through the
following 48 hour period. By light microscopy the glomeruli
appeared normal (Fig. IC) and few PMNs were present at 48
hours (0.36 0.1 PMN/glomerulus, P < 0.001 vs. con A-anti-
con A) (Table 1). By immunofluorescence con A, RbIgG and rat
C3 could be demonstrated in a pattern and intensity that was
similar to that seen in con A-anti-con A treated rats with normal
PMN levels, and equivalent quantities of electron dense depos-
its were present in the subendothelial and, rarely, subepithelial
areas by electron microscopy (Fig. 3). Despite the absence of
neutrophils, mononuclear cells and platelets were still present
in increased numbers in glomeruli.
Neutropenic rats had significantly less elevation of serum
creatinine at 48 hours compared to untreated con A - anti-con A
rats (0.98 0.14 vs. 1.52 0.13 mg/dl, P < 0.05) (Table 1).
Neutrophil depletion reduced proteinuria from 112.6 9.7
mg/24 hr in untreated con A-anti-con A rats to 34.9 6.8 mg/24
hr in PMN-depleted animals (P < 0.00 1).
Demonstration of glomerular iodination and its relation to
neutrophils
The rats perfused with con A - anti-con A and given free 1251
had significant glomerular iodination (1202 184 cpm/38000
glomeruli) compared to control rats receiving con A - normal
RbIgG (45 14 cpm/38000 glomeruli, P < 0.005). Neutrophil
depletion essentially abolished iodination (88 3 cpm/38000
glomeruli, P < 0.005) (Table I). lodination was also demonstra-
ble in isolated GBM preparations from con A - anti-con A rats
(384 71 cpm/38,000 glomeruli), whereas no significant iodina-
tion was detected in con A - normal RbIgG (5 2 cpm) or
ANS-con A-anti-con A (16 4 cpm) rats. Normal rats receiving
con A-anti-con A and neutropenic rats given con A-anti-con A
had similar 1251 blood levels at 48 hours (1478 202 cpm/50 p1
serum vs. 1327 168 cpm/50 pJ serum, respectively). How-
ever, rats treated with con A-normal RbIgG did have lower 1251
blood levels (626 149 cpm/50 pi serum) versus con A-anti-con
A rats (P <0.05).
Glomerular iodination was not simply a consequence of
proteinuria, as demonstrated by the lack of iodinatiori in a
PMN-independent model induced by the injection of the
noncomplement fixing y 2 fraction of sheep antirat GBM
antibody in two rats. Despite the development of marked
proteinuria from day one to two (284 and 235 rng/24 hours), no
PMNs were present in glomeruli by light microscopy and no
significant iodination could be demonstrated in isolated glomer-
uli (123 and 90 cpm/38,000 glomeruli).
Discussion
An in situ model of immune complex GN induced in the rat
was characterized by a proliferative glomerular lesion with
marked PMN infiltration, electron dense subendothelial depos-
its, and proteinuria. The antigen employed was the lectin
concanavalin A, a protein extract derived from the jack bean
Canavalia ensiformis, which binds to terminal a-D-mannose,
a-D-glucose and f3-D-fructose present in glycoproteins of the
glomerular capillary wall [251. The immune complex nephritis
was partially PMN-dependent, as evidenced by the significant
decrease in protein excretion and improvement in glomerular
morphology that occurred when rats were rendered neutropenic
prior to induction of disease. We demonstrated marked in vivo
halogenation of glomerular structures as measured by the
incorporation of 125J into whole glomeruli and glomerular base-
ment membrane in this PMN-mediated model of GN. The
iodination could be prevented if the animals were depleted of
PMNs, and no iodination could be demonstrated in a PMN-
independent model with equivalent proteinuria induced with
noncomplement fixing anti-GBM antibody. Therefore, iodina-
tion of glomeruli appears to correlate with PMN involvement.
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lodination, in the presence of neutrophils, and in tissue
lacking endogenous peroxidase, can be regarded as primarily
reflecting activity of the MPO-H202-halide system [20, 231.
Although iodination can be induced by OH that is indepen-
dent of MPO, this mechanism appears to be of minor impor-
tance in the PMN [351.
The MPO-F1202-halide system was first recognized in the
1960's as a mechanism by which the PMN can kill ingested
microorganisms by the oxidation and halogenation of essential
microbial components [23, 361. This system is also capable of
injuring neighboring cells due to the extracellular release of
MPO and H202 and their reaction with extracellular halides to
form toxic oxidants [20]. We recently demonstrated the ability
of the MPO-H202-halide system to cause glomerular injury [221.
The infusion of small quantities of MPO into the renal artery of
rats, followed by nontoxic concentrations of H202 and a halide
resulted in histologic evidence of glomerular injury and protein-
uria. When '251-iodide was provided as the halide, iodination of
whole glomeruli could be demonstrated. In autoradiographic
studies the silver grains appeared to concentrate in the mesan-
gium and along the glomerular basement membrane. The dem-
onstration of iodination in the PMN-dependent model of im-
mune complex (iN presented in this paper provides the first
evidence that the MPO-H2O2-halide system is involved in
PMN-mediated glomerular disease.
The mechanism of action of the MPO-H202-halide system
most likely relates to the generation of hypohalous acids
(particularly HOC!) and halogens [20, 21]. Although the MPO
system is capable of producing singlet oxygen ('02) it is not
clear whether any substantial amounts are produced under
physiological conditions [37, 381. These oxidants presumably
damage the glomerular basement membrane and the cell mem-
branes of endothelial and possibly epithelial cells. Reactive
oxygen species can injure endothelial cells [39, 40] and degrade
hyaluronic acid, a glycosaminoglycan similar to that present in
GBM [4!]. The mechanism of cell injury by the oxidants may
involve lipid peroxidation, oxidation of sulfhydryl, iron-sulfur
and sulfur-ether groups, chloramine and aldehyde formation,
and possibly damage to nucleic acids and heme enzymes [20].
Although the injury may be a direct consequence of oxidation
and halogenation [201, it may also occur due to activation or
potentiation of proteases [42—451. The MPO system can inhibit
antiproteases [42], activate latent proteases [43, 44], and certain
reactive oxygen species such as H202 may make GBM more
susceptible to proteolytic attack [45]. The MPO system may
also result in the release of vasoactive substances, such as
histamine from mast cells [46] and serotonin from platelets [47].
Thus, the MPO system may lead to glomerular damage either
directly or indirectly. Other products of the PMN may also
contribute to glomerular injury. PMN proteases are capable of
digesting (iBM in vitro [9—Ill, and a recent preliminary report
suggests that the protease inhibitor bis (5-amidino-2-benzimid-
azolyl) methane (BABIM) reduced the "glomerular necrosis"
seen in mice with chronic immune complex disease from
repeated injections with horse apoferritin [48]. Cationic pro-
teins may also be released by PMNs and can adhere to the
glomerular wall on a charge basis [2]. They could neutralize the
anionic charge barrier and result in an increase in vascular
permeability and proteinuria [49]. Finally there are severalFig. 2. Immunofluorescence of a gloinerulus from a rat with con A -
anti-con A induced GN demonstrating linear-granular capillary wall reports that the reactive oxygen species 02 may mediate the
deposits of con A (A), rabbit JgG (B)and rat C1 (C) (x 400). histologic injury in passive serum sickness in nice [12] and the
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Fig. 3. Electron microscopy of the glomerular capillary wall of a rat perfused with con A - anti-con A (A) (x 32000), con A - normalRbIgG (B)(x 32000), and con A - anti-con A in the presence of neutrOpenia (C) (x 34000). Dense subendothelial deposits are present in the rats receiving
con A - anti-con A (arrows), with PMNs displacing the endothelium and abutting on the GBM. The capillary wall of the rat perfused with con
A-normal RbIgG is normal. In the neutropenic rat the subendothelial deposits are present, but no PMN infiltration is seen. (Abbreviations are: CL,
capillary lumen; EN, endothelial cell; EP, epithelial cell; PMN, neutrophil; PLT, platelet; US, urinary space.
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autologous phase of anti-GBM disease in the rat [131 which
would be independent of MPO action. Therefore, PMN medi-
ated injury may involve several mechanisms and the relative
importance of the MPO-H202-halide system in this process
remains to be defined.
Theoretically, if the MPO-H202-halide system were respon-
sible for the proteinuria and iodination observed in our model,
then the administration of catalase, which scavenges H202,
shoUld be protective. However, in studies not reptrted here we
have been unable tO demonstrateany beneficial effect of poly-
ethylene glycol-conjugated catalase (PEG-catalase) (which pro-
longs the circulatory t 1/2 of catalase) on proteinuria or
glomerula iodination in rats with con A-anti-con A GN (unpub-
lished obseryations). This lack of effect of PEG-catalase may
best be explained by the observation that oxidants are released
at sites of nëutrophil or macrophage attachment, and that these
sites are often surrounded by an electron dense seal that
excludes fluid phase proteins > 50,000 mol wt [50—52]. StUdies
on neutrophils exposed to GM and aggregated IgG have
demonstrated that these sites of oxidant release were inacces-
sible to a number of proteins including an ROS inhibitor [51].
Therefore, the negative results of our catalase studies do not
invalidate our conclusion that the con A-anti-con A model is
neutrophil mediated and is associated with activation of the
MPO system.
Our data suggest the following mechanism by which PMNs
mediate glomerular injury. Neutrophils become stimulated
upon their interaction with antigen-antibody complexes [17,
18], Orby interaction with complement activation products such
as C5a [19J. It is also possible inthe model studied here that the
concanavalin A could have stimulated the PMNs directly [53].
However, the lack of iodination in the control animals given con
A-normal RbIgG suggests that con A alone is not a major
stimulus for PMN activation in the glomerulus. Following
stimulation, many of the PMN prodUcts, including MPO are
released extracellularly [20]. MPO being an extremely cationic
protein [54], binds avidly to the negative charges present in the
glomerular capillary wall [22, 55]. There, it reacts with H202
produced by infiltrating neutrophils and monocytes, as well as
possibly by mesangial cells [56, 57] to form more toxic oxygen
radicals which cause local injury. The release of other neutro-
phi! cationic proteins and proteases may augment the damage.
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